Incorporated in June 2024, Avience Biomedicals Limited is an ISO-certified company engaged in the manufacturing, supply, export, distribution, and trading of advanced molecular diagnostic solutions. The company operates in the fields of biotechnology, genomics, and the In-Vitro Diagnostics (IVD) industry, serving a wide range of healthcare and research institutions.

The company has significantly expanded its product portfolio from IVD rapid test kits to a comprehensive range of diagnostic and medical devices. Its offerings cater primarily to the B2B (Business-to-Business) and B2G (Business-to-Government) segments, reflecting its commitment to addressing diverse healthcare and diagnostic requirements.

Avience Biomedicals Limited serves Pathology Laboratories, Microbiology Laboratories, Hospitals, Diagnostic Centers, Research Institutions, and Government Healthcare Organizations across India and international markets.

The company’s state-of-the-art manufacturing facility is located in Noida, Uttar Pradesh, enabling efficient production and quality control of its healthcare products.

Product Portfolio

1. Rapid Diagnostic Test Kits

• AVISURE Dengue Combo Test
• Malaria Rapid Test (Pf/Pv)
• AVISURE Syphilis Rapid Test
• Other infectious disease diagnostic kits

2. Biochemistry Analyzers and Reagents

• BS-240 Fully Automatic Biochemistry Analyzer
• AVIENBIO Albumin Kit
• Various clinical chemistry reagents and consumables

3. Molecular Diagnostic Solutions

• COVID-19 Hid RT-qPCR Assay
• Molecular testing kits for infectious disease detection
• Advanced genomics and PCR-based diagnostic products

4. Hematology Analyzers

• BC-20s 3-Part Hematology Analyzer
• Hematology testing systems and related consumables

5. Medical Devices

• Oxy-5 Oxygen Concentrator
• Oxy-10 Oxygen Concentrator
• Viral Transport Medium (VTM)
• Other healthcare and diagnostic equipment

In addition to its manufacturing operations, the company actively engages in the distribution and trading of medical equipment and diagnostic devices, strengthening its presence across the healthcare value chain.

Human Resources

As of January 31, 2026, Avience Biomedicals Limited employed 75 permanent employees and 33 contractual employees, reflecting its growing operational capabilities and commitment to supporting its expanding business activities.

With a focus on quality, innovation, and customer-centric healthcare solutions, Avience Biomedicals Limited continues to strengthen its position in the biotechnology, diagnostics, and medical devices sectors, both in India and international markets.